Masaaki Shoji

Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial

Yugo Yamashita, Takeshi Morimoto, Nao Muraoka et al. · Circulation · 2023 · 60 citations

Medicine, Pharmacology, Pharmacotherapy +17

Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)

Yugo Yamashita, Takeshi Morimoto, Nao Muraoka et al. · Circulation · 2024 · 21 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid

Tomokazu Matsuura, Shu Wakino, Ayumi Yoshifuji et al. · CEN Case Reports · 2014 · 15 citations · Full text

Medicine, Nephrology, Oncology +9

Electrocardiography Characteristics of Isolated Non-Compaction of Ventricular Myocardium in Japanese Adult Patients

Masaaki Shoji, Takeshi Yamashita, Tokuhisa Uejima et al. · Circulation Journal · 2010 · 13 citations · Full text

Medicine, Cardiology, Pediatrics +12

Advantages and challenges for noninvasive atrial fibrillation ablation

Masaaki Shoji, Koji Inaba, Jun Itami et al. · Journal of Interventional Cardiac Electrophysiology · 2020 · 13 citations

Medicine, Biomedical Engineering, Cardiology +12